APA (7th ed.) Citation

Panaccione, R., Ma, C., Jairath, V., Dignass, A., Joshi, N., Clark, R., . . . Ferrante, M. (2025). Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials. Journal of Crohn's & Colitis, 19(2), 1. https://doi.org/10.1093/ecco-jcc/jjae128

Chicago Style (17th ed.) Citation

Panaccione, Remo, et al. "Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials." Journal of Crohn's & Colitis 19, no. 2 (2025): 1. https://doi.org/10.1093/ecco-jcc/jjae128.

MLA (9th ed.) Citation

Panaccione, Remo, et al. "Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials." Journal of Crohn's & Colitis, vol. 19, no. 2, 2025, p. 1, https://doi.org/10.1093/ecco-jcc/jjae128.